Ontario: UCB's Prescription for Success
Location Canada 2009
In 2006, UCB Pharma Canada was established in Burlington, Ontario, to bring new and improved biopharmaceutical treatment options to Canadian patients who suffer from often-debilitating conditions. Expanding overseas was an important step for UCB in furthering its work in research and the development of treatments. To support such expansion, UCB needed greater access to a skilled work force in the life sciences, opportunities to conduct high-quality clinical trials, as well as access to partnerships with suppliers and other businesses.
The company chose Ontario as its Canadian site for several reasons, including access to reputable business partners within the Greater Toronto area; its proximity to UCB's operations in Rochester, New York; and access to skilled medical researchers. Rob Hamilton, general Manager of UCB Pharma Canada, says "A skilled work force was an important factor. We've had no problem finding people" in Ontario.
Project Announcements
Frontier Lithium Plans Thunder Bay, Ontario, Canada, Chemical Production Operations
03/10/2025
Linamar Corporation Expands Ontario, Canada, Production Operations
02/03/2025
NEO Battery Materials Plans Windsor, Ontario, Canada, Silicon Anode Operations
01/28/2025
AstraZeneca Expands Mississauga, Ontario, Canada, R&D Operations
01/27/2025
Swiss-Based Hoffmann-La Roche Limited Expands Mississauga, Ontario, Canada, Operations
12/12/2024
Greece-Based METLEN Establishes Calgary, Alberta, Canada, Operations
11/29/2024
Most Read
-
NEW NIMBYism: A Threat to The U.S. Economy
Q4 2024
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Designing Beyond the Assembly Line
Q1 2025
-
Forging Solid Foundations
Q1 2025
-
Industries Look for Employees in Nontraditional Spaces Amid Labor Shortage
Q4 2024
-
What to Make of the Rising Trend of Salary Transparency in Job Descriptions
Q4 2024
-
Why Decarbonization Goals Start with Site Selection
Q4 2024